

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | €0.77 | €327.47 €278.35 Free shipping | |
| 180 pills | €0.89 | €188.64 €160.35 | |
| 120 pills | €1.04 | €147.71 €125.55 | |
| 90 pills | €1.15 | €121.01 €102.86 | |
| 60 pills | €1.26 | €88.97 €75.63 | |
| 30 pills | €1.82 | €64.06 €54.45 | |
| 90 pills | €1.57 | €167.28 €142.19 | |
| 60 pills | €1.72 | €121.01 €102.86 | |
| 30 pills | €2.27 | €80.07 €68.06 | |
| 180 pills | €1.51 | €320.35 €272.30 Free shipping | |
| 120 pills | €1.82 | €256.28 €217.83 Free shipping | |
| 90 pills | €1.91 | €201.10 €170.94 | |
| 60 pills | €1.97 | €138.81 €117.99 | |
| 30 pills | €2.53 | €88.97 €75.63 |
Disclaimer: This information is a guide to Tofranil (imipramine) safety and usage. It does not replace medical advice from your doctor or pharmacist. If you have questions about your treatment, talk with a healthcare professional.
Have you ever wondered why a single medicine might help both mood and nerve-related pain? Tofranil, the brand name for imipramine, is a tricyclic antidepressant that works on brain chemicals to improve mood and, in some people, alleviate certain types of chronic pain. It can also be prescribed for conditions beyond depression, such as anxiety disorders and some forms of sleep disturbance, when these are linked to mood regulation or nerve signalling.
Imipramine belongs to an older class of antidepressants that are still used today because they can be effective for specific symptoms that do not respond to other medicines. It acts on several neurotransmitters, including serotonin and norepinephrine, which helps to sharpen mood and resilience. In Ireland, Tofranil may be prescribed when a patient has not fully responded to newer antidepressants or when other symptoms—such as persistent pain or anxiety—are part of the picture.
As a medication that influences brain chemistry, Tofranil can take time to show benefit. Some people notice improvements in sleep, energy, and mood within a few weeks, while others may need longer, ongoing treatment and careful monitoring. Your clinician will tailor the plan to your symptoms, medical history, and other medicines you take, with safety as a primary consideration.
Because Tofranil is a prescription medicine in many cases, check local regulations with a pharmacist or doctor. The information here is designed to help you understand how it works, what to expect, and how to stay safe while using it. Always read the official patient information leaflet that accompanies the medicine for exact instructions and warnings.
Imipramine can interact with other conditions and medicines in ways that may raise risk. Certain people should not take Tofranil at all, or require close medical supervision if a prescription is considered. If you have had an allergic reaction to imipramine or similar drugs in the past, avoid this medicine and discuss alternatives with your clinician.
Individuals with recent heart attack, severe heart block, or certain irregular heart rhythms may be advised against Tofranil because the medicine can affect cardiac conduction. If you have a history of heart disease, conduction abnormalities, or uncontrolled high blood pressure, your doctor will weigh benefits and risks carefully before prescribing it.
People with glaucoma, particularly angle-closure glaucoma, may need to avoid Tofranil or be monitored closely because the drug can increase pressure in the eye in some individuals. Severe liver or kidney disease can alter how imipramine is processed in the body, potentially increasing side effects. A history of mania or hypomania, particularly when spurred by antidepressants, warrants careful assessment before starting Tofranil.
Other medications that affect heart rhythm, mood, or seizure threshold can interact with Tofranil. If you are taking monoamine oxidase inhibitors (MAOIs) or have recently stopped an MAOI, you should not start Tofranil without expert guidance. If you are pregnant, planning pregnancy, or breastfeeding, discuss the risks and alternatives with your healthcare provider to determine the safest option for you and your baby.
For anyone with a history of suicidality or self-harm risk, Tofranil requires careful monitoring, especially at the start of treatment or when doses change. If symptoms worsen, or if you notice new mood swings or behaviours, contact a clinician promptly. If you are considering stopping treatment, do not do so abruptly—this should be done under medical supervision to avoid withdrawal symptoms or a shift in mood symptoms.
If you are unsure about any contraindication or how it applies to your personal health history, consult the official product information leaflet or speak with your pharmacist. They can review your full medical background and help determine if Tofranil is appropriate for you.
Because Tofranil can influence heart rhythm, mental state, and physical alertness, regular monitoring is important. Your clinician may start with a baseline assessment and schedule follow-up checks to watch for signs that the medicine is helping or causing concerns. Pay attention to new symptoms, especially those affecting the heart, nervous system, or eyes, and report them promptly.
Common early monitoring considerations include blood pressure and heart rate, as well as watching for dizziness, fainting, or light-headedness, which can occur when standing up quickly. If you experience chest pain, shortness of breath, or fainting, seek urgent medical help. These could be signs that require immediate evaluation to rule out serious heart-related issues.
Reporting mood changes, worsening anxiety, agitation, or thoughts of self-harm is important, particularly in the first weeks of treatment or after dose adjustments. Imipramine can occasionally trigger mood instability in some patients, so clinicians may adjust the plan or add supportive therapies. If sleep problems or confusion occur, contact your healthcare provider to determine whether adjustments are needed.
Because imipramine affects several receptors, you may notice blurred vision, constipation, dry mouth, urinary retention, or trouble peeing. These effects can be bothersome but are often manageable with hydration, dietary changes, or mild symptomatic care. If they persist, speak with a pharmacist or clinician to discuss alternatives or dose adjustments.
Tofranil can influence heart rhythm and the electrical activity of the heart. Your clinician may advise a baseline assessment and ongoing checks, especially if you have existing heart conditions. Seek urgent medical attention if you experience a sudden severe chest discomfort, fainting, or a dangerously slow or fast heartbeat.
Imipramine can affect sleep, alertness, and mood. If you notice new or worsening confusion, agitation, or behaviors that seem unusual, contact your clinician. In rare cases, a mood worsening or risk of self-harm may occur, necessitating a safety plan and possible medication change.
Blurred vision or difficulty focusing can occur, particularly in low light. Dry mouth and constipation are common, and urinary retention can occur in some people. If you develop severe constipation or abdominal pain, or if vision changes persist, review your treatment with a pharmacist or doctor.
Medications can cause a range of effects, and not everyone experiences them. Side effects are often mild and temporary, but some require medical attention. The following lists group potential effects by body system and present what to watch for, with practical steps to manage them.
Nausea, dry mouth, and changes in appetite are not unusual when starting imipramine. Some people notice constipation, which can be managed with hydration, fibre-rich foods, and gentle activity. Weight changes may occur over longer treatment periods as appetite and energy levels shift.
Drowsiness, dizziness, or light-headedness can affect daytime functioning, particularly after a dose change or at the start of therapy. Headache, fatigue, or slowed thinking may occur but often improve with time. If you experience persistent sleep disturbances or severe headaches, discuss these with your clinician.
Low blood pressure on standing (orthostatic hypotension), palpitations, or a fast heartbeat can occur in some people. If these symptoms are persistent or accompanied by fainting, contact a clinician promptly. In rare cases, imipramine can affect heart rhythm in a way that requires monitoring.
Dry mouth, blurred vision, difficulty urinating, and constipation may be related to anticholinergic activity. These effects are usually manageable but can be bothersome. If urinary retention or persistent symptoms develop, seek medical advice.
Rash or itching is possible, and in rare cases more serious allergic reactions can occur. If you notice swelling of the face or lips, wheezing, or severe skin reactions, seek urgent medical help.
Changes in libido or sexual function can occur with antidepressants, including Tofranil. If these effects become distressing or persistent, discuss options with your clinician. Do not stop the medicine suddenly without professional guidance, as this may worsen symptoms.
Interactions can affect how Tofranil works or increase the risk of side effects. Interactions may involve prescription medicines, over-the-counter drugs, supplements, and certain foods or beverages. Always tell your healthcare provider about all medicines and supplements you take so they can check for potential interactions.
Some antidepressants, antipsychotics, heart medicines, and seizure therapies can interact with imipramine. In particular, combining with other medicines that affect the heart rhythm or mood balance requires careful monitoring. If you are taking a medicine that affects serotonin, norepinephrine, or brain signaling, your clinician might adjust the plan to reduce risk.
Certain cold and allergy remedies, herbal supplements, or nutraceuticals can interact with Tofranil or amplify side effects like drowsiness or dizziness. St John’s wort, in particular, can alter mood regulation and interact with antidepressants. Always tell your pharmacist about non-prescription products you use.
Alcohol can increase sedative effects or worsen dizziness and coordination problems. Combining Tofranil with alcohol is generally discouraged. Caffeine or other stimulants may also interact with how you feel on treatment, so moderation and awareness are advised.
Medicines that affect heart rhythm or clotting, as well as agents that influence liver enzymes, can alter Tofranil levels. If you are planning surgery or starting a new therapy, inform all medical teams about your Tofranil use so they can coordinate care safely.
Special populations require careful consideration because Tofranil can affect development, lactation, or organ function differently. If you are pregnant or breastfeeding, or caring for a child, talk with your clinician about risks and alternatives before starting or continuing Tofranil.
In older adults, the risk of side effects such as dizziness, confusion, and balance problems can be higher. Dose adjustments and closer monitoring may be warranted. For children and adolescents, the clinician weighs the benefits against any potential risks, as information on safety can vary by age and condition being treated.
Imipramine is processed by the liver and cleared by the kidneys. In people with liver or kidney disease, or in the elderly, the drug’s effects can last longer or cause more noticeable side effects. Your clinician may propose additional checks or adjustments to the treatment plan.
Pregnancy and breastfeeding: imipramine crosses the placenta and can be excreted in breast milk. If you are pregnant, planning a pregnancy, or breastfeeding, discuss with a clinician to understand the potential impact on you and your baby and to consider safer alternatives if needed.
Tofranil is typically taken by mouth, as directed by a clinician. Some people prefer to take it with food to reduce stomach upset, though your doctor may tailor timing to your symptoms and other medications. Do not alter your dose or frequency without medical advice, even if you feel better or worse, as this can influence safety and effectiveness.
Keep a consistent schedule. If you miss a dose, consult your pharmacist or clinician for guidance on the best course of action. Do not double-dose to compensate unless advised by a professional. Store the medication at room temperature, away from light and moisture, out of reach of children and pets.
If your mood or pain symptoms worsen, or if you notice alarming signs such as severe chest symptoms, fainting, or sudden changes in mood, contact a clinician promptly. For serious or life-threatening symptoms, seek urgent medical help rather than waiting to see if they improve on their own.
Disposal and recycling: do not keep outdated or unused Tofranil. Follow local disposal guidelines or ask the pharmacist how to safely discard unused medicines. Do not share your prescription with others, and do not use someone else’s medicine, even if your symptoms are similar.
Alcohol can increase drowsiness and dizziness and may worsen mood symptoms in some people. It is generally best to limit or avoid alcohol while using Tofranil, especially at the start of treatment or after dose changes. If you have concerns about alcohol use, talk with your clinician.
If you miss a dose, the guidance depends on your schedule and the advice of your clinician. Do not double up on doses without guidance, as this can raise the risk of side effects. If you frequently forget doses, speaking with your pharmacist about a practical schedule can help maintain steady levels.
Imipramine can cause dizziness or drowsiness in some people. If you notice these effects, avoid driving or using heavy machinery until you understand how the medicine affects you. Your clinician can adjust treatment or timing to reduce this risk if needed.
Weight changes can occur with many antidepressants, including Tofranil, and may vary over time. If weight change is a concern, discuss lifestyle strategies and monitoring with your clinician. Do not assume a specific pattern will occur for you, as responses can differ.
Herbal supplements can interact with antidepressants. St John’s Wort, in particular, may affect serotonin levels and interact with Tofranil. Do not start or stop herbal products without speaking to your healthcare professional first.
Pregnancy poses different risks and benefits with any antidepressant. If you become pregnant or are planning pregnancy while on Tofranil, consult your clinician to weigh the options and adjust treatment if needed.
Some people notice improvements within a few weeks, while others may require longer under careful supervision. If there is no clear improvement after several weeks, or if symptoms worsen, speak with your clinician about adjustments or alternatives.
Chest pain, severe shortness of breath, or an abnormal heartbeat are signs that require urgent medical evaluation. Seek medical help promptly rather than waiting to see if symptoms improve on their own.
Most routine blood tests are not routinely required specifically for Tofranil, but your clinician may monitor certain tests if you have other health conditions or are taking multiple medicines. If you have concerns about blood tests, ask your pharmacist or doctor what to expect in your case.
Abruptly stopping imipramine can cause withdrawal-like symptoms or a return of mood symptoms. If you wish to stop, your clinician will usually guide a gradual taper. Do not stop without professional advice.
If there is little to no improvement after a course of treatment, or if symptoms worsen, contact your clinician. They may adjust the dose, switch to a different medicine, or add another therapy to help manage your symptoms.
Older adults may be more sensitive to side effects like dizziness, confusion, or balance problems. Dose adjustments and closer monitoring are commonly considered. Always inform health professionals about age-related concerns when starting or stopping Tofranil.
Most people adapt over time, but some may continue to experience reduced alertness or slower reaction times during treatment. If this happens, adjust activities accordingly and discuss with your clinician whether a change in treatment is appropriate.
The official patient information leaflet that accompanies Tofranil provides device-specific details, warnings, and instructions. Your pharmacist is a reliable source for practical questions about how Tofranil fits with your current medicines and daily routines. For broader safety guidance and up-to-date recommendations, consult national health guidelines and trusted medical resources as well as your clinician.
When in doubt about safety, side effects, or interactions, the safest course is to talk with a healthcare professional. They can help interpret symptoms, review all medications you take, and personalize advice to your health history and treatment goals.
Consider keeping a simple symptom diary during the first weeks of treatment. Note mood changes, sleep quality, energy levels, appetite, and any side effects. This can help you and your clinician assess whether Tofranil is helping and whether any adjustments are needed.
Tofranil can be an effective option for certain mood and pain-related conditions, but it requires careful management. Contraindications, warnings about heart and mental health, side effects by body system, and potential interactions all shape how it is used. By staying informed, reporting promptly any concerning symptoms, and maintaining open communication with your healthcare team, you can navigate treatment safely.
Always follow the official leaflet and your clinician’s instructions. If you are unsure about any safety aspect or if something feels different after starting Tofranil, seek guidance from a pharmacist or doctor. Your health team is there to help you use this medicine as safely as possible while aiming for the best possible outcome.
Official product information and patient leaflets provided with Tofranil contain the most accurate details about dosing, safety, interactions, and contraindications. Your pharmacist can also supply local guidelines relevant to Ireland and clarify how Tofranil fits with other medicines you take. For any unfamiliar terms or uncertainties, check with a healthcare professional to ensure understanding and safe use.
14–21 days. Free from €182.27 .
5–9 days. €27.34
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
